Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F) in the framework of the Council Decision on new psychoactive substances 16. Červenec 2018, rubrika EUDA news
5. Leden 2026 EU Drugs Agency welcomes its new Executive Director, Dr Lorraine Nolan This week, the European Union Drugs Agency (EUDA) welcomes its new Executive Director Dr Lorraine Nolan (Ireland), as she...